Diabetes-Risiko-Check

Early diabetes risk assessment measuring fasting glucose and long-term blood sugar control. Blood sample after 12-hour fast. Results within 2-3 days. Critical for early detection before progression to type 2 diabetes when lifestyle interventions are most effective. Biomarkers tested: Fasting Glucose - immediate blood sugar level after overnight fast, normal <100 mg/dL (5.6 mmol/L), prediabetes 100-125 mg/dL, diabetes ≥126 mg/dL on two separate tests; HbA1c (Glycated Hemoglobin) - 2-3 month average blood sugar reflected in glucose-coated hemoglobin, normal <5.7%, prediabetes 5.7-6.4%, diabetes ≥6.5%, superior to single glucose measurement for diabetes screening. Risk factors for diabetes include: family history, overweight/obesity (BMI >25), sedentary lifestyle, age >45, history of gestational diabetes, PCOS, high blood pressure (>140/90), abnormal cholesterol (HDL <35 or triglycerides >250), prediabetes history. Symptoms of high blood sugar: increased thirst and urination, unexplained weight loss, blurred vision, slow-healing wounds, frequent infections, tingling hands/feet. Price includes blood draw and 19% VAT. Early intervention with diet, exercise, and weight loss can prevent or reverse prediabetes. Recommended annual testing for high-risk individuals, every 3 years for adults 45+.

Diabetes and metabolic screening tests measure how well your body processes glucose — your primary fuel source. Fasting glucose gives a snapshot of your blood sugar after an overnight fast, while HbA1c reveals your average blood sugar over the past 2–3 months by measuring the percentage of hemoglobin proteins coated with sugar. An insulin test can detect insulin resistance — where your cells stop responding efficiently to insulin — often years before blood sugar levels rise into the diabetic range. This early detection window is critical because prediabetes and insulin resistance are reversible with lifestyle changes, while advanced type 2 diabetes requires lifelong management.